Issue 4, 2025

Correction: Design, synthesis, and in silico studies of new quinazolinones tagged thiophene, thienopyrimidine, and thienopyridine scaffolds as antiproliferative agents with potential p38α MAPK kinase inhibitory effects

Abstract

Correction for ‘Design, synthesis, and in silico studies of new quinazolinones tagged thiophene, thienopyrimidine, and thienopyridine scaffolds as antiproliferative agents with potential p38α MAPK kinase inhibitory effects’ by Aisha A. Alsfouk et al., RSC Adv., 2025, 15, 1407–1424, https://doi.org/10.1039/D4RA06744D.

Associated articles

Article information

Article type
Correction
Submitted
21 Jan 2025
Accepted
21 Jan 2025
First published
27 Jan 2025
This article is Open Access
Creative Commons BY license

RSC Adv., 2025,15, 2758-2758

Correction: Design, synthesis, and in silico studies of new quinazolinones tagged thiophene, thienopyrimidine, and thienopyridine scaffolds as antiproliferative agents with potential p38α MAPK kinase inhibitory effects

A. A. Alsfouk, I. M. M. Othman, M. M. Anwar, A. Saleh and E. S. Nossier, RSC Adv., 2025, 15, 2758 DOI: 10.1039/D5RA90011E

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements